Global Neuroscience Antibodies and Assays Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 01 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

According to our (Global Info Research) latest study, the global Neuroscience Antibodies and Assays market size was valued at USD 2485.3 million in 2022 and is forecast to a readjusted size of USD 3627.5 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Neuroscience Antibodies and Assays market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Neuroscience Antibodies and Assays market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neuroscience Antibodies and Assays market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neuroscience Antibodies and Assays market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neuroscience Antibodies and Assays market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuroscience Antibodies and Assays
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuroscience Antibodies and Assays market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Abcam, Bio-Rad, Merck and Cell Signaling Technology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Neuroscience Antibodies and Assays market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Consumables
    Instruments

Market segment by Application
    Pharmaceutical & Biotechnology Companies
    Academic & Research Institutes
    Hospitals & Diagnostic Centers

Market segment by players, this report covers
    Thermo Fisher
    Abcam
    Bio-Rad
    Merck
    Cell Signaling Technology
    Genscript
    Rockland Immunochemicals
    BioLegend
    Santa Cruz Biotechnology
    Roche
    Siemens

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neuroscience Antibodies and Assays product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neuroscience Antibodies and Assays, with revenue, gross margin and global market share of Neuroscience Antibodies and Assays from 2018 to 2023.
Chapter 3, the Neuroscience Antibodies and Assays competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neuroscience Antibodies and Assays market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuroscience Antibodies and Assays.
Chapter 13, to describe Neuroscience Antibodies and Assays research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Neuroscience Antibodies and Assays
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Neuroscience Antibodies and Assays by Type
        1.3.1 Overview: Global Neuroscience Antibodies and Assays Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Neuroscience Antibodies and Assays Consumption Value Market Share by Type in 2022
        1.3.3 Consumables
        1.3.4 Instruments
    1.4 Global Neuroscience Antibodies and Assays Market by Application
        1.4.1 Overview: Global Neuroscience Antibodies and Assays Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical & Biotechnology Companies
        1.4.3 Academic & Research Institutes
        1.4.4 Hospitals & Diagnostic Centers
    1.5 Global Neuroscience Antibodies and Assays Market Size & Forecast
    1.6 Global Neuroscience Antibodies and Assays Market Size and Forecast by Region
        1.6.1 Global Neuroscience Antibodies and Assays Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Neuroscience Antibodies and Assays Market Size by Region, (2018-2029)
        1.6.3 North America Neuroscience Antibodies and Assays Market Size and Prospect (2018-2029)
        1.6.4 Europe Neuroscience Antibodies and Assays Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Neuroscience Antibodies and Assays Market Size and Prospect (2018-2029)
        1.6.6 South America Neuroscience Antibodies and Assays Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Neuroscience Antibodies and Assays Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Thermo Fisher
        2.1.1 Thermo Fisher Details
        2.1.2 Thermo Fisher Major Business
        2.1.3 Thermo Fisher Neuroscience Antibodies and Assays Product and Solutions
        2.1.4 Thermo Fisher Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Thermo Fisher Recent Developments and Future Plans
    2.2 Abcam
        2.2.1 Abcam Details
        2.2.2 Abcam Major Business
        2.2.3 Abcam Neuroscience Antibodies and Assays Product and Solutions
        2.2.4 Abcam Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Abcam Recent Developments and Future Plans
    2.3 Bio-Rad
        2.3.1 Bio-Rad Details
        2.3.2 Bio-Rad Major Business
        2.3.3 Bio-Rad Neuroscience Antibodies and Assays Product and Solutions
        2.3.4 Bio-Rad Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Bio-Rad Recent Developments and Future Plans
    2.4 Merck
        2.4.1 Merck Details
        2.4.2 Merck Major Business
        2.4.3 Merck Neuroscience Antibodies and Assays Product and Solutions
        2.4.4 Merck Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Merck Recent Developments and Future Plans
    2.5 Cell Signaling Technology
        2.5.1 Cell Signaling Technology Details
        2.5.2 Cell Signaling Technology Major Business
        2.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Product and Solutions
        2.5.4 Cell Signaling Technology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Cell Signaling Technology Recent Developments and Future Plans
    2.6 Genscript
        2.6.1 Genscript Details
        2.6.2 Genscript Major Business
        2.6.3 Genscript Neuroscience Antibodies and Assays Product and Solutions
        2.6.4 Genscript Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Genscript Recent Developments and Future Plans
    2.7 Rockland Immunochemicals
        2.7.1 Rockland Immunochemicals Details
        2.7.2 Rockland Immunochemicals Major Business
        2.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Product and Solutions
        2.7.4 Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Rockland Immunochemicals Recent Developments and Future Plans
    2.8 BioLegend
        2.8.1 BioLegend Details
        2.8.2 BioLegend Major Business
        2.8.3 BioLegend Neuroscience Antibodies and Assays Product and Solutions
        2.8.4 BioLegend Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 BioLegend Recent Developments and Future Plans
    2.9 Santa Cruz Biotechnology
        2.9.1 Santa Cruz Biotechnology Details
        2.9.2 Santa Cruz Biotechnology Major Business
        2.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product and Solutions
        2.9.4 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Santa Cruz Biotechnology Recent Developments and Future Plans
    2.10 Roche
        2.10.1 Roche Details
        2.10.2 Roche Major Business
        2.10.3 Roche Neuroscience Antibodies and Assays Product and Solutions
        2.10.4 Roche Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Roche Recent Developments and Future Plans
    2.11 Siemens
        2.11.1 Siemens Details
        2.11.2 Siemens Major Business
        2.11.3 Siemens Neuroscience Antibodies and Assays Product and Solutions
        2.11.4 Siemens Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Siemens Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Neuroscience Antibodies and Assays Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Neuroscience Antibodies and Assays by Company Revenue
        3.2.2 Top 3 Neuroscience Antibodies and Assays Players Market Share in 2022
        3.2.3 Top 6 Neuroscience Antibodies and Assays Players Market Share in 2022
    3.3 Neuroscience Antibodies and Assays Market: Overall Company Footprint Analysis
        3.3.1 Neuroscience Antibodies and Assays Market: Region Footprint
        3.3.2 Neuroscience Antibodies and Assays Market: Company Product Type Footprint
        3.3.3 Neuroscience Antibodies and Assays Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Neuroscience Antibodies and Assays Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Neuroscience Antibodies and Assays Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Neuroscience Antibodies and Assays Consumption Value Market Share by Application (2018-2023)
    5.2 Global Neuroscience Antibodies and Assays Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Neuroscience Antibodies and Assays Consumption Value by Type (2018-2029)
    6.2 North America Neuroscience Antibodies and Assays Consumption Value by Application (2018-2029)
    6.3 North America Neuroscience Antibodies and Assays Market Size by Country
        6.3.1 North America Neuroscience Antibodies and Assays Consumption Value by Country (2018-2029)
        6.3.2 United States Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        6.3.3 Canada Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        6.3.4 Mexico Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Neuroscience Antibodies and Assays Consumption Value by Type (2018-2029)
    7.2 Europe Neuroscience Antibodies and Assays Consumption Value by Application (2018-2029)
    7.3 Europe Neuroscience Antibodies and Assays Market Size by Country
        7.3.1 Europe Neuroscience Antibodies and Assays Consumption Value by Country (2018-2029)
        7.3.2 Germany Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        7.3.3 France Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        7.3.5 Russia Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        7.3.6 Italy Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region
        8.3.1 Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Region (2018-2029)
        8.3.2 China Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        8.3.3 Japan Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        8.3.4 South Korea Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        8.3.5 India Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        8.3.7 Australia Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Neuroscience Antibodies and Assays Consumption Value by Type (2018-2029)
    9.2 South America Neuroscience Antibodies and Assays Consumption Value by Application (2018-2029)
    9.3 South America Neuroscience Antibodies and Assays Market Size by Country
        9.3.1 South America Neuroscience Antibodies and Assays Consumption Value by Country (2018-2029)
        9.3.2 Brazil Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        9.3.3 Argentina Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country
        10.3.1 Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Country (2018-2029)
        10.3.2 Turkey Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)
        10.3.4 UAE Neuroscience Antibodies and Assays Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Neuroscience Antibodies and Assays Market Drivers
    11.2 Neuroscience Antibodies and Assays Market Restraints
    11.3 Neuroscience Antibodies and Assays Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Neuroscience Antibodies and Assays Industry Chain
    12.2 Neuroscience Antibodies and Assays Upstream Analysis
    12.3 Neuroscience Antibodies and Assays Midstream Analysis
    12.4 Neuroscience Antibodies and Assays Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Neuroscience Antibodies and Assays Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Neuroscience Antibodies and Assays Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Neuroscience Antibodies and Assays Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Neuroscience Antibodies and Assays Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Thermo Fisher Company Information, Head Office, and Major Competitors
    Table 6. Thermo Fisher Major Business
    Table 7. Thermo Fisher Neuroscience Antibodies and Assays Product and Solutions
    Table 8. Thermo Fisher Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Thermo Fisher Recent Developments and Future Plans
    Table 10. Abcam Company Information, Head Office, and Major Competitors
    Table 11. Abcam Major Business
    Table 12. Abcam Neuroscience Antibodies and Assays Product and Solutions
    Table 13. Abcam Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Abcam Recent Developments and Future Plans
    Table 15. Bio-Rad Company Information, Head Office, and Major Competitors
    Table 16. Bio-Rad Major Business
    Table 17. Bio-Rad Neuroscience Antibodies and Assays Product and Solutions
    Table 18. Bio-Rad Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Bio-Rad Recent Developments and Future Plans
    Table 20. Merck Company Information, Head Office, and Major Competitors
    Table 21. Merck Major Business
    Table 22. Merck Neuroscience Antibodies and Assays Product and Solutions
    Table 23. Merck Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Merck Recent Developments and Future Plans
    Table 25. Cell Signaling Technology Company Information, Head Office, and Major Competitors
    Table 26. Cell Signaling Technology Major Business
    Table 27. Cell Signaling Technology Neuroscience Antibodies and Assays Product and Solutions
    Table 28. Cell Signaling Technology Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Cell Signaling Technology Recent Developments and Future Plans
    Table 30. Genscript Company Information, Head Office, and Major Competitors
    Table 31. Genscript Major Business
    Table 32. Genscript Neuroscience Antibodies and Assays Product and Solutions
    Table 33. Genscript Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Genscript Recent Developments and Future Plans
    Table 35. Rockland Immunochemicals Company Information, Head Office, and Major Competitors
    Table 36. Rockland Immunochemicals Major Business
    Table 37. Rockland Immunochemicals Neuroscience Antibodies and Assays Product and Solutions
    Table 38. Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Rockland Immunochemicals Recent Developments and Future Plans
    Table 40. BioLegend Company Information, Head Office, and Major Competitors
    Table 41. BioLegend Major Business
    Table 42. BioLegend Neuroscience Antibodies and Assays Product and Solutions
    Table 43. BioLegend Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. BioLegend Recent Developments and Future Plans
    Table 45. Santa Cruz Biotechnology Company Information, Head Office, and Major Competitors
    Table 46. Santa Cruz Biotechnology Major Business
    Table 47. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product and Solutions
    Table 48. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Santa Cruz Biotechnology Recent Developments and Future Plans
    Table 50. Roche Company Information, Head Office, and Major Competitors
    Table 51. Roche Major Business
    Table 52. Roche Neuroscience Antibodies and Assays Product and Solutions
    Table 53. Roche Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Roche Recent Developments and Future Plans
    Table 55. Siemens Company Information, Head Office, and Major Competitors
    Table 56. Siemens Major Business
    Table 57. Siemens Neuroscience Antibodies and Assays Product and Solutions
    Table 58. Siemens Neuroscience Antibodies and Assays Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Siemens Recent Developments and Future Plans
    Table 60. Global Neuroscience Antibodies and Assays Revenue (USD Million) by Players (2018-2023)
    Table 61. Global Neuroscience Antibodies and Assays Revenue Share by Players (2018-2023)
    Table 62. Breakdown of Neuroscience Antibodies and Assays by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Neuroscience Antibodies and Assays, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 64. Head Office of Key Neuroscience Antibodies and Assays Players
    Table 65. Neuroscience Antibodies and Assays Market: Company Product Type Footprint
    Table 66. Neuroscience Antibodies and Assays Market: Company Product Application Footprint
    Table 67. Neuroscience Antibodies and Assays New Market Entrants and Barriers to Market Entry
    Table 68. Neuroscience Antibodies and Assays Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Neuroscience Antibodies and Assays Consumption Value (USD Million) by Type (2018-2023)
    Table 70. Global Neuroscience Antibodies and Assays Consumption Value Share by Type (2018-2023)
    Table 71. Global Neuroscience Antibodies and Assays Consumption Value Forecast by Type (2024-2029)
    Table 72. Global Neuroscience Antibodies and Assays Consumption Value by Application (2018-2023)
    Table 73. Global Neuroscience Antibodies and Assays Consumption Value Forecast by Application (2024-2029)
    Table 74. North America Neuroscience Antibodies and Assays Consumption Value by Type (2018-2023) & (USD Million)
    Table 75. North America Neuroscience Antibodies and Assays Consumption Value by Type (2024-2029) & (USD Million)
    Table 76. North America Neuroscience Antibodies and Assays Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. North America Neuroscience Antibodies and Assays Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. North America Neuroscience Antibodies and Assays Consumption Value by Country (2018-2023) & (USD Million)
    Table 79. North America Neuroscience Antibodies and Assays Consumption Value by Country (2024-2029) & (USD Million)
    Table 80. Europe Neuroscience Antibodies and Assays Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Europe Neuroscience Antibodies and Assays Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Europe Neuroscience Antibodies and Assays Consumption Value by Application (2018-2023) & (USD Million)
    Table 83. Europe Neuroscience Antibodies and Assays Consumption Value by Application (2024-2029) & (USD Million)
    Table 84. Europe Neuroscience Antibodies and Assays Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Neuroscience Antibodies and Assays Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Type (2018-2023) & (USD Million)
    Table 87. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Type (2024-2029) & (USD Million)
    Table 88. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Application (2018-2023) & (USD Million)
    Table 89. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Application (2024-2029) & (USD Million)
    Table 90. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Region (2018-2023) & (USD Million)
    Table 91. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value by Region (2024-2029) & (USD Million)
    Table 92. South America Neuroscience Antibodies and Assays Consumption Value by Type (2018-2023) & (USD Million)
    Table 93. South America Neuroscience Antibodies and Assays Consumption Value by Type (2024-2029) & (USD Million)
    Table 94. South America Neuroscience Antibodies and Assays Consumption Value by Application (2018-2023) & (USD Million)
    Table 95. South America Neuroscience Antibodies and Assays Consumption Value by Application (2024-2029) & (USD Million)
    Table 96. South America Neuroscience Antibodies and Assays Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. South America Neuroscience Antibodies and Assays Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Type (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Type (2024-2029) & (USD Million)
    Table 100. Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Application (2018-2023) & (USD Million)
    Table 101. Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Application (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Country (2018-2023) & (USD Million)
    Table 103. Middle East & Africa Neuroscience Antibodies and Assays Consumption Value by Country (2024-2029) & (USD Million)
    Table 104. Neuroscience Antibodies and Assays Raw Material
    Table 105. Key Suppliers of Neuroscience Antibodies and Assays Raw Materials
List of Figures
    Figure 1. Neuroscience Antibodies and Assays Picture
    Figure 2. Global Neuroscience Antibodies and Assays Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Neuroscience Antibodies and Assays Consumption Value Market Share by Type in 2022
    Figure 4. Consumables
    Figure 5. Instruments
    Figure 6. Global Neuroscience Antibodies and Assays Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Neuroscience Antibodies and Assays Consumption Value Market Share by Application in 2022
    Figure 8. Pharmaceutical & Biotechnology Companies Picture
    Figure 9. Academic & Research Institutes Picture
    Figure 10. Hospitals & Diagnostic Centers Picture
    Figure 11. Global Neuroscience Antibodies and Assays Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Neuroscience Antibodies and Assays Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Neuroscience Antibodies and Assays Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Neuroscience Antibodies and Assays Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Neuroscience Antibodies and Assays Consumption Value Market Share by Region in 2022
    Figure 16. North America Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Neuroscience Antibodies and Assays Revenue Share by Players in 2022
    Figure 22. Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Neuroscience Antibodies and Assays Market Share in 2022
    Figure 24. Global Top 6 Players Neuroscience Antibodies and Assays Market Share in 2022
    Figure 25. Global Neuroscience Antibodies and Assays Consumption Value Share by Type (2018-2023)
    Figure 26. Global Neuroscience Antibodies and Assays Market Share Forecast by Type (2024-2029)
    Figure 27. Global Neuroscience Antibodies and Assays Consumption Value Share by Application (2018-2023)
    Figure 28. Global Neuroscience Antibodies and Assays Market Share Forecast by Application (2024-2029)
    Figure 29. North America Neuroscience Antibodies and Assays Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Neuroscience Antibodies and Assays Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Neuroscience Antibodies and Assays Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Neuroscience Antibodies and Assays Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Neuroscience Antibodies and Assays Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Neuroscience Antibodies and Assays Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Neuroscience Antibodies and Assays Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Neuroscience Antibodies and Assays Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Neuroscience Antibodies and Assays Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Neuroscience Antibodies and Assays Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Neuroscience Antibodies and Assays Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Neuroscience Antibodies and Assays Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Neuroscience Antibodies and Assays Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
    Figure 63. Neuroscience Antibodies and Assays Market Drivers
    Figure 64. Neuroscience Antibodies and Assays Market Restraints
    Figure 65. Neuroscience Antibodies and Assays Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Neuroscience Antibodies and Assays in 2022
    Figure 68. Manufacturing Process Analysis of Neuroscience Antibodies and Assays
    Figure 69. Neuroscience Antibodies and Assays Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens

Related Reports

Global Neuroscience Antibodies and Assays Supply, Demand and Key Producers, 2023-2029

Global Neuroscience Antibodies and Assays Supply, Demand and Key Producers, 2023-2029

date 29 Jan 2023

date Medical Care

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

Global Neuroscience Antibodies and Assays Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Neuroscience Antibodies and Assays Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Neuroscience Antibodies and Assays market size was valued at USD 2485.3 million in 2023 and is forecast to a readjusted size of USD 3627.5 million by 2030 with a CAGR of 5.6% during review period.

Product Tags

Neuroscience Antibodies and Assays

Neuroscience Antibodies and Assays Technology

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>